Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.25p
   
  • Change Today:
      0.11p
  • 52 Week High: 3.42p
  • 52 Week Low: 0.85p
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 984,928
  • Market Cap: £9.37m
  • RiskGrade: 328

Deal with Barclays    Trade now with Barclays Stockbrokers

Income Statement - Normalised

  £ (Millions) £ (Millions)
31-Dec-10 31-Dec-09
Continuing Operations    
Revenue 0.03 22.05
     
EBITDA (4.14) 10.34
Depreciation & Amortisation (0.04) (0.04)
     
Operating Profit/(Loss) (4.18) 10.30
Interest Payable n/a (1.26)
Interest Receivable/Investment Income 1.71 0.06
     
Group Profit after Interest (2.47) 9.10
Share of Assoc Cos/JV Profits n/a n/a
     
Profit Before Tax (2.47) 9.10
Tax 0.49 (1.00)
     
Profit After Tax (1.98) 8.10
     
Discontinued Operations    
Profit After Tax n/a n/a
     
PROFIT FOR PERIOD (1.98) 8.10
     
Attributable to:    
Equity Holders of Parent Company (1.98) 8.10
Minority Interests n/a n/a
     
Equity Dividends cn/a cn/a
Retained Profit/(Loss) for the Financial Year c(1.98) c8.10


Per Share Record - Normalised 31-Dec-10 31-Dec-09
Continuing EPS    
Earnings per Share - Basic (2.44p) 10.46p
Earnings per Share - Diluted (2.44p) 9.99p
Earnings per Share - Adjusted (2.44p) 10.46p
Continuing and Discontinued EPS    
Earnings per Share - Basic (2.44p) 10.46p
Earnings per Share - Diluted (2.44p) 9.99p
Earnings per Share - Adjusted (2.44p) 10.46p
     
Dividend per Share n/a n/a


Key Financals 31-Dec-10 31-Dec-09
Shares in Issue (millions)    
Shares in Issue - Year End 81.53 81.09
Weighted Average 81.17 77.50
Diluted 81.17 81.11
     
Performance Ratios    
Continuing Operations    
Operating Margin (12,876.59%) 46.70%
Return on Capital Employed n/a 57.88%
Continuing Operations & Discontinued Operations    
Return on Equity (12.39%) 44.81%
     
Financial Status    
Continuing Operations    
Interest Cover - Continuing (1,235.79) 8.22
Revenue per Share 0.040p 28.46p
Pre-Tax Profit Per Share - Continuing (3.05p) 11.74p
     
Market Data    
Continuing Operations    
Earnings Per Share Growth - Basic n/a n/a
Earnings Per Share Growth - Diluted n/a n/a
PE Ratio - Company Adjusted n/a 9.1
PEG - Company Adjusted n/a n/a
Dividend Cover n/a n/a
Continuing Operations & Discontinued Operations    
Earnings per Share - Company Adjusted n/a n/a
Earnings per Share - Diluted n/a n/a
PE Ratio - Company Adjusted n/a 9.1
PEG - Company Adjusted n/a n/a
Dividend Cover n/a n/a
     
Market Capitalisation £ (Millions) 70.93 77.24
Dividend per Share n/a n/a
Dividend Yield 0.0% 0.0%
Dividend per Share Growth n/a n/a

Key

* GAAP

a. Includes discontinued activities

b. Includes preference dividends

c. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page